“The first 2-3 million doses of the Covid Oxford-Irbm-AstraZeneca vaccine should arrive in Italy by the end of November if the ongoing trial proceeds positively, after the temporary suspension due to a suspicious reaction on a volunteer then proved unrelated to the vaccine candidate “. Piero di Lorenzo, president of the Irbm of Pomezia, confirmed that the research work continues to move forward.The volunteer had been affected by spinal inflammation, acute transverse myelitis, which consists of inflammation in one or more adjacent segments spinal cord. However, the panel of independent experts that examined the matter established within days that this reaction was not related to the inoculation of the candidate vaccine. This experiment, explains di Lorenzo, “is in fact conducted in double blindness: this means that neither the doctors nor the patients know which of the volunteers the candidate vaccine is administered to and which only placebo. So – he concludes – the suspicious reaction could also having occurred on a volunteer who had taken the placebo and not the drug “.